Ilaprazole

Pharmacokinetic/Pharmacodynamic Study of Ilaprazole to Evaluate the Effect of CYP Genetic Polymorphism

Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety

Study to Evaluate Pharmacokinetic Drug Interactions and Safety of Naproxen, Aceclofenac, Celecoxib and Ilaprazole

Study to Evaluate Pharmacokinetic Drug Interactions and Safety of Ilaprazole and Aceclofenac

Safety and Efficacy of Ilaprazole 5, 20 and 40 mg QD and Lansoprazole 30 mg QD on Healing of Erosive Esophagitis

IIaprazole for the Treatment and Prevention of Peptic Ulcer Bleeding in Chinese Patients

Efficacy Study of Ilaprazole to Treat Erosive Esophgitis

Efficacy/Safety Study as H. Pylori Eradication of Triple Therapy for 7 Days Treatment

Ilaprazole for the Treatment and Prevention of Peptic Ulcer Bleeding in Chinese Patients

Phase III Study to Evaluate Safety and Efficacy of Ilaprazole in Patients With NERD

Study to Evaluate the Efficacy and Safety of Ilaprazole 10 mg in Prevention NSAIDs Associated Peptic Ulcer

Effects of Ilaprazole on Ulcer Healing Rate and Prevention of Gastrointestinal Bleeding in the Patients Undergone ESD.

The Pilot Study on Tailored Eradication Therapy According to Clarithromycin Resistance in H.Pylori Patients

The Prospective Study on the Effect of Ilaprazole in Non-erosive Reflux Disease Patients; Focused on Histologic Findings and Inflammatory Biomarker

Efficacy and Safety of 1-week Triple Therapy With Ilaprazole for the Eradication of Helicobacter Pylori

Antimicrobial Susceptibility Testing Guided Triple Therapy in Salvage Helicobacter Pylori Treatment